Mannose-binding lectin (MBL) genotype in relation to risk of nosocomial infection in pre-term neonates in the neonatal intensive care unit

Clinical Microbiology and Infection

Volumn 14, Issue 2, 2008, Pages 130-135

  Van Der Zwet, W C ^a   Catsburg, A ^a   Van Elburg, R M ^a   Savelkoul, P H M ^a   Vandenbroucke grauls, C M J E ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Coagulase negative staphylococci; Haplotypes; Immune response; Mannose binding lectin; Neonates; Nosocomial infection

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2;

ARTICLE; ARTIFICIAL VENTILATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA ISOLATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; HAPLOTYPE; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; INTRAVASCULAR CATHETER; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN POLYMORPHISM; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEPSIS;

STAPHYLOCOCCUS;

EID: 38049036445     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01886.x     Document Type: Article

References (43)

1. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496-1505.
2. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358: 637-638.
3. Koch A, Melbye M, Sørensen M et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001; 285: 1316-1321.
4. Epstein J, Eichbaum Q, Sheriff S, Ezekowitz RAB. The collectins in innate immunity. Curr Opin Immunol 1996; 8: 29-35.
5. Selander B, Mårtensson U, Weintraub A et al. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest 2006; 116: 1425-1434.
6. Kilpatrick DC. Mannan-binding lectin: Clinical significance and applications. Biochim Biophys Acta 2002; 1572: 401-413.
7. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996; 98: 357-361.
8. Drews MB, Ludwig AC, Leititis JU, Daschner FD. Low birth weight and nosocomial infection of neonates in a neonatal intensive care unit. J Hosp Infect 1995; 30: 65-72.
9. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis RW. Nosocomial infection rates in US children's hospitals'neonatal and pediatric intensive care units. Am J Infect Control 2001; 29: 152-157.
10. Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol 1998; 22: 2-14.
11. Drossou V, Kanakoudi F, Tzimouli V et al. Impact of prematurity, stress and sepsis on the neutrophil respiratory burst activity of neonates. Biol Neonate 1997; 72: 201-209.
12. Falconer AE, Carr R, Edwards SW. Impaired neutrophil phagocytosis in preterm neonates: Lack of correlation with expression of immunoglobulin or complement receptors. Biol Neonate 1995; 68: 264-269.
13. Sullivan SE, Staba SL, Gersting JA et al. Circulating concentrations of chemokines in cord blood, neonates, and adults. Pediatr Res 2002; 51: 653-657.
14. Gessler P, Kirchmann N, Kientsch-Engel R, Haas N, Lasch P, Kachel W. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood 1993; 82: 3177-3182.
15. Gessler P, Nebe T, Birle A, Haas N, Kachel W. Neutrophil respiratory burst in term and preterm neonates without signs of infection and in those with increased levels of C-reactive protein. Pediatr Res 1996; 39: 843-848.
16. Bodamer OA, Mitterer G, Maurer W et al. Evidence for an association between mannose-binding lectin2 (MBL2) gene polymorphisms and pre-term birth. Genet Med 2006; 8: 518-524.
17. Van der Zwet WC, Kaiser AM, Van Elburg RM et al. Nosocomial infections in a Dutch neonatal intensive care unit: Surveillance study with definitions for infection specifically adapted for neonates. J Hosp Infect 2005; 61: 300-311.
18. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
19. Catsburg A, Van der Zwet WC, Morré SA, Vandenbroucke-Grauls CMJE, Savelkoul PHM. Multi SNP analysis with real time PCR on very low amounts of DNA derived from plasma and dried blood. J Immunol Methods 2007; 321: 135-141.
20. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from Southeast Africa and South America. J Immunol 1998; 161: 3169-3175.
21. Garred P, Strǿm JJ, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003; 188: 1394-1403.
22. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 2001; 358: 614-618.
23. Malhotra R, Willis AC, Lopez Bernal A, Thiel S, Sim RB. Mannan-binding protein levels in human amniotic fluid during gestation and its interaction with collectin receptor from amnion cells. Immunology 1994; 82: 439-444.
24. Lau YL, Chan SY, Turner MW, Fong J, Karlberg J. Mannose-binding protein in preterm neonates: Development profile and clinical significance. Clin Exp Immunol 1995; 102: 649-654.
25. Maruyama H, Galvan M, Waffarn F, Tenner AJ. Human cord blood leukocyte innate immune responses to defense collagens. Pediatr Res 2003; 54: 724-731.
26. Kilpatrick DC, Liston WA, Midgley PC. Mannan-binding protein in human umbilical cord blood. Nat Immunol 1996; 15: 234-240.
27. Terai I, Kobayashi K. Perinatal changes in serum mannose-binding protein (MBP) levels. Immunol Lett 1993; 38: 185-187.
28. Sumiya M, Super M, Tabona P et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991; 337: 1569-1570.
29. Thiel S, Bjerke T, Hansen D, Poulsen LK, Schiøtz PO, Jensenius JC. Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr Allergy Immunol 1995; 6: 20-23.
30. Hilgendorff A, Schmidt R, Bohnert A, Merz C, Bein G, Gortner L. Host defence lectins in preterm neonates. Acta Paediatr 2005; 94: 794-799.
31. Frakking FNJ, Brouwer N, Zweers D et al. High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol 2006; 145: 5-12.
32. Schibler KR, Liechty KW, White WL, Christensen RD. Production of granulocyte colony-stimulating factor invitro by monocytes from preterm and term neonates. Blood 1993; 82: 2478-2484.
33. Fleer A, Gerards LJ, Verhoef J. Host defence to bacterial infection in the neonate. J Hosp Infect 1988; 11 (suppl A): 320-327.
34. Mullighan CG, Heatley S, Doherty K et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524-3529.
35. Turner MW. Mannose-binding lectin: The pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
36. Aittoniemi J, Baer M, Soppi E, Vesikari T, Miettinen A. Mannan binding lectin deficiency and concomitant immunodefects. Arch Dis Child 1998; 78: 245-248.
37. Ahrens P, Kattner E, Köhler B et al. Mutations of genes involved in the innate immune system as predictor of sepsis in very low birth weight infants. Pediatr Res 2004; 55: 652-656.
38. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688-693.
39. Stengaard-Pedersen K, Thiel S, Gadjeva M et al. Inherited deficiency of mannan-binding lectin-associated serine protease2. N Engl J Med 2003; 349: 554-560.
40. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Meth 2000; 241: 33-42.
41. Kuipers S, Aerts PC, Sjöholm AG, Harmsen T, Van Dijk H. A haemolytic assay for the estimation of functional mannose-binding lectin levels in human serum. J Immunol Meth 2002; 268: 149-157.
42. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003; 40: 73-84.
43. Takahashi K, Ezekowitz AB. The role of the mannose-binding lectin in innate immunity. Clin Infect Dis 2005; 41: S440-S444.